$2.4m Capital Raise to Further BREASTEST Commercialisation
Filed with ASX · · 3 pages · English
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- Breakthrough Results a Major Step Towards Commercialisation
- BCAL Enters US Product Development Agreement with Precion
- Appendix 4D & Interim Report
- 7 February Announcement - Additional Information
- Recent Analysis Significantly Improves Commercial Prospects
Later from BCAL Diagnostics
- Preliminary Final Report
- Share Purchase Plan Offer Booklet
- Appointment of Strategic CEO to Lead Commercial Launch
- Pause in Trading
- Trading Halt
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics